Hummel, M., S. Bentink, H. Berger, W. Klapper, S. Wessendorf, T. F. Barth, H.-W. Bernd, S. B. Cogliatti, J. Dierlamm, A. C. Feller, M.-L. Hansmann, E. Haralambieva, L. Harder, D. Hasenclever, M. Kühn, D. Lenze, P. Lichter, J. I. Martin-Subero, P. Möller, H.-K. Müller-Hermelink, G. Ott, R. M. Parwaresch, C. Pott, A. Rosenwald, M. Rosolowski, C. Schwaenen, B. Stürzenhofecker, M. Szczepanowski, H. Trautmann, H.-H. Wacker, R. Spang, M. Loeffler, L. Trümper, H. Stein and R. Siebert: A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling. In: The New England Journal of Medicine : NEJM / Publ. by the Massachusetts Medical Society 354, 23, 2419-2430 (2006).
Wojnowski, L., B. Kulle, M. Schirmer, G. Schlüter, A. Schmidt, A. Rosenberger, S. Vonhof, H. Bickeböller, M. R. Toliat, E.-K. Suk, M. Tzvetkov, A. Kruger, S. Seifert, M. Kloess, H. Hahn, M. Loeffler, P. Nürnberg, M. Pfreundschuh, L. Trümper, J. Brockmöller and G. Hasenfuss: NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. In: Circulation 112, 24, 3754-3762 (2005).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.